Evaluation of aminotransferases, particularly ALT, is also relevant for the assessment of patients with any of a wide array of other hepatic conditions, including metabolic dysfunction−associated steatotic liver disease, autoimmune hepatitis, and hepatitis B infection [27]. This evidence concerns the gene GPT and hepatitis B virus infection.